BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 29069649)

  • 21. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
    Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE
    Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.
    Shemer A; Kivity S; Shovman O; Bashi T; Perry O; Watad A; Ben-Ami Shor D; Volkov A; Barshack I; Bragazzi NL; Krule A; Fridkin M; Amital H; Blank M; Shoenfeld Y
    Clin Exp Immunol; 2018 Aug; 193(2):160-166. PubMed ID: 29698559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.
    Mun CH; Kim JO; Ahn SS; Yoon T; Kim SJ; Ko E; Noh HD; Park YB; Jung HJ; Kim TS; Lee SW; Park SG
    Biomaterials; 2019 Nov; 220():119408. PubMed ID: 31394431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
    Wong M; La Cava A; Singh RP; Hahn BH
    J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
    Suwannaroj S; Lagoo A; McMurray RW
    Lupus; 2001; 10(8):562-7. PubMed ID: 11530998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-
    Moriyama R; Katsumata Y; Okamoto Y; Harigai M
    Lupus; 2024 Jul; 33(8):816-827. PubMed ID: 38622764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
    Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
    Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus.
    Balabanian K; Couderc J; Bouchet-Delbos L; Amara A; Berrebi D; Foussat A; Baleux F; Portier A; Durand-Gasselin I; Coffman RL; Galanaud P; Peuchmaur M; Emilie D
    J Immunol; 2003 Mar; 170(6):3392-400. PubMed ID: 12626600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
    Keil A; Hall SR; Körner M; Herrmann M; Schmid RA; Frese S
    Arthritis Res Ther; 2016 Oct; 18(1):243. PubMed ID: 27770825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway.
    Jacob N; Yang H; Pricop L; Liu Y; Gao X; Zheng SG; Wang J; Gao HX; Putterman C; Koss MN; Stohl W; Jacob CO
    J Immunol; 2009 Feb; 182(4):2532-41. PubMed ID: 19201910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production.
    Li B; Yue Y; Dong C; Shi Y; Xiong S
    Clin Exp Rheumatol; 2014; 32(5):705-14. PubMed ID: 25151985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K; Maeda Y; Shimano K; Murase M; Mochiduki S; Takemoto K; Kakimoto T; Utsumi H; Oshita K; Kataoka H
    J Immunol Res; 2019; 2019():5821589. PubMed ID: 31930150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
    Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
    Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbon monoxide inhibits T cell activation in target organs during systemic lupus erythematosus.
    Mackern-Oberti JP; Obreque J; Méndez GP; Llanos C; Kalergis AM
    Clin Exp Immunol; 2015 Oct; 182(1):1-13. PubMed ID: 26095291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-17 promotes murine lupus.
    Amarilyo G; Lourenço EV; Shi FD; La Cava A
    J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.